Naltrexone Completed Phase 3 Trials for Heroin Dependence / Opiate Dependence Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00577408Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone
NCT00834080ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals
NCT01389167Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia
NCT00678418ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence
NCT01180647Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail